Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fat Emulsions, Intravenous | 63 | 2024 | 314 | 10.050 |
Why?
|
Parenteral Nutrition | 88 | 2024 | 659 | 9.860 |
Why?
|
Fish Oils | 53 | 2024 | 481 | 6.710 |
Why?
|
Intestinal Diseases | 24 | 2024 | 504 | 4.560 |
Why?
|
Soybean Oil | 31 | 2024 | 139 | 4.210 |
Why?
|
Liver Diseases | 30 | 2024 | 1296 | 3.760 |
Why?
|
Cholestasis | 26 | 2023 | 377 | 3.240 |
Why?
|
Short Bowel Syndrome | 23 | 2024 | 353 | 2.650 |
Why?
|
Enteral Nutrition | 24 | 2023 | 792 | 1.650 |
Why?
|
Fatty Acids, Essential | 16 | 2020 | 97 | 1.600 |
Why?
|
Parenteral Nutrition, Total | 13 | 2022 | 304 | 1.590 |
Why?
|
Parenteral Nutrition Solutions | 11 | 2024 | 30 | 1.320 |
Why?
|
Aluminum | 4 | 2017 | 152 | 1.180 |
Why?
|
Spices | 1 | 2024 | 11 | 0.960 |
Why?
|
Liver Failure | 7 | 2024 | 250 | 0.930 |
Why?
|
Dietary Supplements | 11 | 2024 | 3405 | 0.890 |
Why?
|
Pharmacy Service, Hospital | 3 | 2019 | 134 | 0.870 |
Why?
|
Fatty Acids, Omega-3 | 16 | 2024 | 1389 | 0.860 |
Why?
|
Nutritional Requirements | 5 | 2019 | 275 | 0.840 |
Why?
|
Catheter-Related Infections | 8 | 2024 | 273 | 0.840 |
Why?
|
Dietary Fats | 11 | 2019 | 1994 | 0.780 |
Why?
|
Gastrointestinal Diseases | 6 | 2024 | 1197 | 0.740 |
Why?
|
Triglycerides | 19 | 2023 | 2458 | 0.730 |
Why?
|
Intestines | 10 | 2024 | 1909 | 0.730 |
Why?
|
Growth | 3 | 2020 | 365 | 0.690 |
Why?
|
Drug Contamination | 2 | 2014 | 152 | 0.680 |
Why?
|
Parenteral Nutrition, Home | 5 | 2021 | 39 | 0.660 |
Why?
|
Fatty Liver | 12 | 2024 | 782 | 0.660 |
Why?
|
Bilirubin | 11 | 2023 | 437 | 0.660 |
Why?
|
Catheterization, Central Venous | 8 | 2024 | 527 | 0.650 |
Why?
|
Deficiency Diseases | 3 | 2017 | 74 | 0.630 |
Why?
|
Infant Nutritional Physiological Phenomena | 7 | 2021 | 351 | 0.600 |
Why?
|
Infant Nutrition Disorders | 1 | 2017 | 70 | 0.570 |
Why?
|
Infant, Premature | 9 | 2024 | 2104 | 0.570 |
Why?
|
Infant | 46 | 2024 | 36183 | 0.560 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2017 | 295 | 0.540 |
Why?
|
Docosahexaenoic Acids | 9 | 2024 | 908 | 0.530 |
Why?
|
Micronutrients | 3 | 2017 | 381 | 0.520 |
Why?
|
Child Nutrition Disorders | 1 | 2017 | 150 | 0.520 |
Why?
|
Nutritional Status | 6 | 2022 | 1612 | 0.520 |
Why?
|
Arachidonic Acid | 6 | 2024 | 427 | 0.510 |
Why?
|
Functional Food | 2 | 2024 | 19 | 0.470 |
Why?
|
Infant, Newborn | 35 | 2024 | 26280 | 0.460 |
Why?
|
Malabsorption Syndromes | 3 | 2019 | 135 | 0.460 |
Why?
|
Infant, Premature, Diseases | 6 | 2021 | 710 | 0.450 |
Why?
|
Infant, Very Low Birth Weight | 3 | 2021 | 406 | 0.440 |
Why?
|
Fatty Acids | 12 | 2023 | 1805 | 0.430 |
Why?
|
Swimming | 1 | 2013 | 208 | 0.410 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2019 | 842 | 0.400 |
Why?
|
Critical Illness | 6 | 2022 | 2722 | 0.390 |
Why?
|
Child Development | 4 | 2019 | 2302 | 0.380 |
Why?
|
Child | 44 | 2024 | 80086 | 0.370 |
Why?
|
Drug Compounding | 5 | 2020 | 246 | 0.370 |
Why?
|
Energy Intake | 9 | 2023 | 2134 | 0.360 |
Why?
|
Intestinal Absorption | 4 | 2024 | 400 | 0.350 |
Why?
|
alpha-Tocopherol | 3 | 2019 | 126 | 0.340 |
Why?
|
Liver | 16 | 2024 | 7531 | 0.340 |
Why?
|
Aspartate Aminotransferases | 4 | 2020 | 417 | 0.340 |
Why?
|
Food, Formulated | 1 | 2010 | 101 | 0.340 |
Why?
|
Humans | 131 | 2024 | 760437 | 0.320 |
Why?
|
Protective Agents | 2 | 2019 | 150 | 0.300 |
Why?
|
Medication Errors | 4 | 2017 | 783 | 0.290 |
Why?
|
Drug Incompatibility | 3 | 2024 | 11 | 0.290 |
Why?
|
Child, Preschool | 21 | 2024 | 42209 | 0.270 |
Why?
|
Phytosterols | 4 | 2019 | 55 | 0.260 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 342 | 0.260 |
Why?
|
Bone Diseases, Metabolic | 3 | 2014 | 409 | 0.260 |
Why?
|
Intestinal Volvulus | 2 | 2023 | 82 | 0.260 |
Why?
|
Practice Guidelines as Topic | 9 | 2021 | 7380 | 0.250 |
Why?
|
Hyperlipidemias | 1 | 2010 | 771 | 0.250 |
Why?
|
Hypertriglyceridemia | 1 | 2007 | 293 | 0.240 |
Why?
|
Enterocolitis, Necrotizing | 3 | 2012 | 326 | 0.230 |
Why?
|
Plant Oils | 5 | 2016 | 198 | 0.230 |
Why?
|
Bacteremia | 3 | 2023 | 979 | 0.230 |
Why?
|
Drug Stability | 1 | 2024 | 291 | 0.230 |
Why?
|
Plants, Medicinal | 1 | 2024 | 165 | 0.220 |
Why?
|
Alkaline Phosphatase | 3 | 2017 | 866 | 0.220 |
Why?
|
Phospholipids | 6 | 2013 | 786 | 0.220 |
Why?
|
Edetic Acid | 1 | 2024 | 283 | 0.220 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2023 | 156 | 0.220 |
Why?
|
Alanine Transaminase | 4 | 2018 | 606 | 0.220 |
Why?
|
Infant, Low Birth Weight | 3 | 2012 | 868 | 0.220 |
Why?
|
Mice, Inbred C57BL | 18 | 2024 | 22121 | 0.220 |
Why?
|
Disease Models, Animal | 21 | 2023 | 18216 | 0.210 |
Why?
|
Swine | 8 | 2024 | 5915 | 0.200 |
Why?
|
Phytotherapy | 1 | 2024 | 296 | 0.200 |
Why?
|
Linoleic Acid | 3 | 2017 | 158 | 0.200 |
Why?
|
Male | 62 | 2024 | 360035 | 0.200 |
Why?
|
Heparin | 3 | 2024 | 1633 | 0.190 |
Why?
|
Liver Function Tests | 4 | 2014 | 522 | 0.190 |
Why?
|
Emulsions | 6 | 2023 | 153 | 0.180 |
Why?
|
Nursing Staff, Hospital | 1 | 2004 | 348 | 0.180 |
Why?
|
Intestinal Neoplasms | 1 | 2023 | 311 | 0.180 |
Why?
|
Dietary Fiber | 1 | 2024 | 759 | 0.180 |
Why?
|
Refeeding Syndrome | 1 | 2020 | 16 | 0.180 |
Why?
|
Lipids | 5 | 2012 | 3342 | 0.170 |
Why?
|
PPAR gamma | 2 | 2023 | 483 | 0.170 |
Why?
|
Drug Evaluation | 1 | 2021 | 642 | 0.170 |
Why?
|
Animals | 44 | 2024 | 168253 | 0.170 |
Why?
|
Treatment Outcome | 19 | 2023 | 64591 | 0.170 |
Why?
|
Antithrombins | 1 | 2022 | 294 | 0.170 |
Why?
|
Digestive System Surgical Procedures | 2 | 2023 | 573 | 0.170 |
Why?
|
Pharmacists | 2 | 2019 | 259 | 0.170 |
Why?
|
Recovery of Function | 1 | 2010 | 2975 | 0.170 |
Why?
|
Intestine, Small | 2 | 2023 | 1205 | 0.160 |
Why?
|
Liver Cirrhosis | 4 | 2015 | 1934 | 0.160 |
Why?
|
Product Labeling | 1 | 2019 | 76 | 0.160 |
Why?
|
Hospitals, Pediatric | 5 | 2016 | 1859 | 0.160 |
Why?
|
Liver Transplantation | 4 | 2020 | 2332 | 0.160 |
Why?
|
Retrospective Studies | 24 | 2024 | 80430 | 0.150 |
Why?
|
Latex | 1 | 1997 | 49 | 0.150 |
Why?
|
Endotoxemia | 1 | 2019 | 196 | 0.150 |
Why?
|
Nutrition Assessment | 2 | 2020 | 728 | 0.150 |
Why?
|
United States Food and Drug Administration | 3 | 2014 | 1663 | 0.150 |
Why?
|
Female | 46 | 2024 | 391875 | 0.150 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2021 | 326 | 0.140 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2015 | 5663 | 0.140 |
Why?
|
gamma-Glutamyltransferase | 1 | 2017 | 144 | 0.140 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2016 | 1116 | 0.140 |
Why?
|
Nutritional Support | 2 | 2022 | 172 | 0.140 |
Why?
|
Intubation, Gastrointestinal | 1 | 2018 | 166 | 0.140 |
Why?
|
Energy Metabolism | 4 | 2012 | 2875 | 0.140 |
Why?
|
Vitamin K | 1 | 2019 | 318 | 0.140 |
Why?
|
Infection Control | 1 | 2004 | 985 | 0.140 |
Why?
|
Chemistry, Pharmaceutical | 1 | 1997 | 274 | 0.140 |
Why?
|
Case-Control Studies | 4 | 2020 | 22097 | 0.140 |
Why?
|
Hepatic Insufficiency | 1 | 2016 | 14 | 0.130 |
Why?
|
Mucolipidoses | 2 | 2019 | 82 | 0.130 |
Why?
|
Rest | 2 | 2012 | 915 | 0.130 |
Why?
|
Feeding Methods | 1 | 2016 | 35 | 0.130 |
Why?
|
Medication Reconciliation | 1 | 2017 | 153 | 0.130 |
Why?
|
Dietary Proteins | 1 | 2020 | 953 | 0.130 |
Why?
|
Pruritus | 1 | 2019 | 378 | 0.130 |
Why?
|
Environmental Exposure | 1 | 2010 | 4443 | 0.120 |
Why?
|
Patient Transfer | 1 | 2022 | 793 | 0.120 |
Why?
|
Cross Infection | 1 | 2004 | 1438 | 0.120 |
Why?
|
Vitamin E | 1 | 2019 | 871 | 0.120 |
Why?
|
Disease Outbreaks | 1 | 2004 | 1762 | 0.120 |
Why?
|
Gastric Emptying | 1 | 2017 | 242 | 0.120 |
Why?
|
Weight Gain | 5 | 2020 | 2346 | 0.120 |
Why?
|
Ileum | 1 | 2017 | 557 | 0.120 |
Why?
|
Postoperative Care | 2 | 2018 | 1471 | 0.120 |
Why?
|
Citrulline | 1 | 2014 | 106 | 0.110 |
Why?
|
Hair | 1 | 2017 | 497 | 0.110 |
Why?
|
PPAR alpha | 2 | 2023 | 175 | 0.110 |
Why?
|
Sterilization | 1 | 2014 | 133 | 0.110 |
Why?
|
United States | 17 | 2022 | 72202 | 0.110 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2014 | 224 | 0.110 |
Why?
|
Mucositis | 1 | 2014 | 108 | 0.110 |
Why?
|
Mice | 22 | 2024 | 81402 | 0.100 |
Why?
|
Malnutrition | 2 | 2016 | 644 | 0.100 |
Why?
|
Fatty Acids, Omega-6 | 3 | 2013 | 226 | 0.100 |
Why?
|
Inflammation | 4 | 2024 | 10746 | 0.100 |
Why?
|
Stomach | 1 | 2017 | 694 | 0.100 |
Why?
|
Medication Systems, Hospital | 1 | 1993 | 154 | 0.100 |
Why?
|
Infusions, Intravenous | 2 | 2016 | 2217 | 0.100 |
Why?
|
Health Care Rationing | 1 | 2015 | 437 | 0.100 |
Why?
|
Body Fluid Compartments | 1 | 2011 | 50 | 0.100 |
Why?
|
Gastrointestinal Tract | 2 | 2016 | 831 | 0.100 |
Why?
|
Hyperbilirubinemia | 2 | 2016 | 74 | 0.100 |
Why?
|
Mouth Mucosa | 1 | 2014 | 430 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1248 | 0.090 |
Why?
|
Adolescent | 15 | 2020 | 88196 | 0.090 |
Why?
|
Reperfusion Injury | 1 | 2018 | 1023 | 0.090 |
Why?
|
Depressive Disorder | 1 | 2023 | 3728 | 0.090 |
Why?
|
Lipid Regulating Agents | 1 | 2010 | 21 | 0.090 |
Why?
|
Ethanol | 2 | 2023 | 1324 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2020 | 10180 | 0.090 |
Why?
|
Maximum Allowable Concentration | 1 | 2010 | 63 | 0.090 |
Why?
|
Age Factors | 5 | 2019 | 18379 | 0.090 |
Why?
|
Cysteine | 1 | 2015 | 892 | 0.090 |
Why?
|
Interleukin-6 | 4 | 2019 | 3209 | 0.090 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2012 | 540 | 0.090 |
Why?
|
Adult | 18 | 2023 | 220781 | 0.080 |
Why?
|
Health | 1 | 2012 | 398 | 0.080 |
Why?
|
Growth Disorders | 1 | 2014 | 653 | 0.080 |
Why?
|
Prospective Studies | 13 | 2021 | 54339 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1807 | 0.080 |
Why?
|
C-Reactive Protein | 5 | 2020 | 3822 | 0.080 |
Why?
|
Eicosapentaenoic Acid | 4 | 2017 | 560 | 0.080 |
Why?
|
Vaccines | 1 | 2017 | 836 | 0.080 |
Why?
|
Food Contamination | 1 | 2010 | 191 | 0.080 |
Why?
|
Osmolar Concentration | 1 | 2009 | 661 | 0.080 |
Why?
|
Anti-Bacterial Agents | 3 | 2020 | 7424 | 0.080 |
Why?
|
Hypersensitivity | 1 | 1997 | 1157 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2022 | 3956 | 0.080 |
Why?
|
Bile Acids and Salts | 2 | 2023 | 393 | 0.070 |
Why?
|
Anti-Infective Agents, Local | 1 | 2010 | 247 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2318 | 0.070 |
Why?
|
Probability | 2 | 2014 | 2476 | 0.070 |
Why?
|
Biliary Tract | 1 | 2008 | 135 | 0.070 |
Why?
|
Family | 1 | 2018 | 3189 | 0.070 |
Why?
|
Streptomyces | 2 | 1997 | 91 | 0.070 |
Why?
|
Vomiting | 2 | 2023 | 652 | 0.070 |
Why?
|
Risk Factors | 9 | 2020 | 74055 | 0.070 |
Why?
|
Bone and Bones | 2 | 2014 | 2566 | 0.070 |
Why?
|
Glutamine | 2 | 2012 | 576 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1669 | 0.070 |
Why?
|
Serum Albumin | 1 | 2009 | 675 | 0.070 |
Why?
|
Glucose | 4 | 2017 | 4342 | 0.070 |
Why?
|
Dietary Carbohydrates | 2 | 2012 | 891 | 0.070 |
Why?
|
Incidence | 6 | 2022 | 21322 | 0.070 |
Why?
|
Metabolome | 1 | 2013 | 986 | 0.070 |
Why?
|
Vitamins | 3 | 2022 | 1635 | 0.060 |
Why?
|
Immunity | 1 | 2012 | 997 | 0.060 |
Why?
|
Electrolytes | 3 | 2017 | 274 | 0.060 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 2852 | 0.060 |
Why?
|
Consumer Product Safety | 1 | 2006 | 122 | 0.060 |
Why?
|
Microvilli | 2 | 2019 | 234 | 0.060 |
Why?
|
Cholecystitis, Acute | 1 | 2006 | 74 | 0.060 |
Why?
|
Clinical Competence | 2 | 2018 | 4777 | 0.060 |
Why?
|
Societies, Scientific | 2 | 2018 | 222 | 0.060 |
Why?
|
Body Composition | 2 | 2011 | 2421 | 0.060 |
Why?
|
Osteoporosis | 1 | 2015 | 1603 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1384 | 0.060 |
Why?
|
Anemia | 1 | 2014 | 1508 | 0.060 |
Why?
|
Ceftriaxone | 1 | 2006 | 175 | 0.060 |
Why?
|
Blood Glucose | 1 | 2019 | 6380 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3436 | 0.060 |
Why?
|
Amino Acids | 3 | 2017 | 1717 | 0.060 |
Why?
|
Animals, Newborn | 2 | 2023 | 2676 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1886 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2272 | 0.060 |
Why?
|
Hypoglycemia | 1 | 2011 | 884 | 0.060 |
Why?
|
Risk Assessment | 3 | 2019 | 23953 | 0.060 |
Why?
|
Cholelithiasis | 1 | 2006 | 407 | 0.060 |
Why?
|
Compassionate Use Trials | 1 | 2024 | 50 | 0.060 |
Why?
|
Tyramine | 1 | 2023 | 53 | 0.060 |
Why?
|
Diet | 4 | 2024 | 8058 | 0.060 |
Why?
|
Selegiline | 1 | 2023 | 32 | 0.060 |
Why?
|
Abdominal Pain | 2 | 2023 | 1069 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5835 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3685 | 0.060 |
Why?
|
Metabolomics | 1 | 2013 | 1653 | 0.060 |
Why?
|
Hydroxamic Acids | 1 | 2006 | 481 | 0.050 |
Why?
|
Hyperglycemia | 1 | 2011 | 1371 | 0.050 |
Why?
|
Double-Blind Method | 6 | 2015 | 12320 | 0.050 |
Why?
|
Dyslipidemias | 1 | 2010 | 868 | 0.050 |
Why?
|
Radiotherapy | 1 | 2010 | 1498 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 286 | 0.050 |
Why?
|
Blood Platelets | 1 | 2013 | 2478 | 0.050 |
Why?
|
Adipose Tissue | 2 | 2011 | 3306 | 0.050 |
Why?
|
Cell Membrane | 3 | 2012 | 3685 | 0.050 |
Why?
|
Fibrosis | 2 | 2023 | 2048 | 0.050 |
Why?
|
Bone Density | 1 | 2015 | 3549 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 389 | 0.050 |
Why?
|
Equipment Design | 1 | 2009 | 3510 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 3028 | 0.050 |
Why?
|
Swine, Miniature | 1 | 2023 | 961 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15257 | 0.050 |
Why?
|
Area Under Curve | 2 | 2017 | 1633 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 3115 | 0.050 |
Why?
|
Safety | 1 | 2005 | 1150 | 0.050 |
Why?
|
Reference Values | 1 | 2008 | 4921 | 0.040 |
Why?
|
Living Donors | 1 | 2005 | 639 | 0.040 |
Why?
|
Models, Biological | 1 | 2016 | 9462 | 0.040 |
Why?
|
Length of Stay | 3 | 2020 | 6413 | 0.040 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1899 | 0.040 |
Why?
|
Parents | 1 | 2013 | 3563 | 0.040 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2022 | 363 | 0.040 |
Why?
|
Survival Rate | 2 | 2014 | 12698 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2691 | 0.040 |
Why?
|
Lipopolysaccharides | 2 | 2019 | 2205 | 0.040 |
Why?
|
Young Adult | 5 | 2020 | 59068 | 0.040 |
Why?
|
Tyrosine | 1 | 2023 | 1438 | 0.040 |
Why?
|
Infant Formula | 1 | 2020 | 193 | 0.040 |
Why?
|
Prescriptions | 1 | 2022 | 386 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2023 | 857 | 0.040 |
Why?
|
Phosphorus | 1 | 2020 | 336 | 0.040 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2019 | 85 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2021 | 318 | 0.040 |
Why?
|
Societies, Medical | 3 | 2020 | 3904 | 0.040 |
Why?
|
Time Factors | 7 | 2020 | 39947 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2011 | 1385 | 0.040 |
Why?
|
Body Mass Index | 2 | 2016 | 12932 | 0.040 |
Why?
|
Spectrophotometry, Atomic | 1 | 2017 | 82 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2016 | 15820 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 427 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2022 | 395 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2019 | 4355 | 0.040 |
Why?
|
Hospitals, Teaching | 1 | 2002 | 1155 | 0.040 |
Why?
|
Anthropometry | 2 | 2015 | 1349 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2693 | 0.040 |
Why?
|
International Normalized Ratio | 1 | 2019 | 382 | 0.040 |
Why?
|
Filtration | 1 | 2018 | 228 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2021 | 793 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6471 | 0.040 |
Why?
|
Gastrointestinal Contents | 1 | 2017 | 42 | 0.030 |
Why?
|
Rats | 3 | 2022 | 23712 | 0.030 |
Why?
|
alpha-Linolenic Acid | 1 | 2017 | 144 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 495 | 0.030 |
Why?
|
Birth Weight | 2 | 2016 | 2098 | 0.030 |
Why?
|
Nutritional Sciences | 1 | 2018 | 144 | 0.030 |
Why?
|
Body Weight | 2 | 2018 | 4614 | 0.030 |
Why?
|
Magnesium | 1 | 2020 | 809 | 0.030 |
Why?
|
Micelles | 1 | 2017 | 192 | 0.030 |
Why?
|
Language Development | 1 | 2017 | 183 | 0.030 |
Why?
|
Gastrointestinal Transit | 1 | 2017 | 99 | 0.030 |
Why?
|
Safflower Oil | 1 | 2015 | 29 | 0.030 |
Why?
|
Pilot Projects | 3 | 2018 | 8611 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 802 | 0.030 |
Why?
|
Potassium | 1 | 2020 | 1311 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2023 | 15627 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2015 | 39078 | 0.030 |
Why?
|
Patient Care Team | 2 | 2022 | 2517 | 0.030 |
Why?
|
Infant Food | 1 | 1995 | 140 | 0.030 |
Why?
|
Survival Analysis | 1 | 2008 | 10075 | 0.030 |
Why?
|
Solutions | 2 | 2011 | 411 | 0.030 |
Why?
|
Vietnam | 1 | 2016 | 409 | 0.030 |
Why?
|
Dietetics | 1 | 2014 | 34 | 0.030 |
Why?
|
Drug Labeling | 1 | 2017 | 248 | 0.030 |
Why?
|
Gastroparesis | 1 | 2017 | 136 | 0.030 |
Why?
|
Pulmonary Ventilation | 1 | 2016 | 372 | 0.030 |
Why?
|
Cesarean Section | 1 | 2023 | 1393 | 0.030 |
Why?
|
Motor Skills | 1 | 2017 | 520 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1535 | 0.030 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1993 | 55 | 0.030 |
Why?
|
Heart Diseases | 1 | 2006 | 2785 | 0.030 |
Why?
|
Cohort Studies | 2 | 2024 | 41366 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2016 | 590 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2012 | 4808 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2394 | 0.030 |
Why?
|
Organ Size | 1 | 2018 | 2252 | 0.030 |
Why?
|
Acetaminophen | 1 | 2017 | 554 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1337 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2388 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2013 | 271 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 2017 | 824 | 0.020 |
Why?
|
Membrane Lipids | 1 | 2013 | 252 | 0.020 |
Why?
|
Oxidative Stress | 2 | 2013 | 3108 | 0.020 |
Why?
|
Automation | 1 | 2014 | 587 | 0.020 |
Why?
|
Boston | 2 | 2016 | 9326 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2000 | 1406 | 0.020 |
Why?
|
Diarrhea, Infantile | 1 | 2011 | 101 | 0.020 |
Why?
|
Bacteria | 2 | 2000 | 2217 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1379 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1139 | 0.020 |
Why?
|
Lung | 2 | 2022 | 9973 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2012 | 393 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14565 | 0.020 |
Why?
|
Checklist | 1 | 2018 | 827 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2006 | 3759 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2015 | 1596 | 0.020 |
Why?
|
Instillation, Drug | 1 | 2010 | 32 | 0.020 |
Why?
|
Platelet Count | 1 | 2013 | 780 | 0.020 |
Why?
|
Abdomen | 1 | 2017 | 1127 | 0.020 |
Why?
|
Inclusion Bodies | 1 | 2011 | 281 | 0.020 |
Why?
|
Vitamin D | 2 | 2015 | 3303 | 0.020 |
Why?
|
Spleen | 1 | 2016 | 2296 | 0.020 |
Why?
|
Diet, Fat-Restricted | 1 | 2012 | 329 | 0.020 |
Why?
|
Feces | 1 | 2017 | 1494 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2017 | 2425 | 0.020 |
Why?
|
Adipogenesis | 1 | 2012 | 367 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10759 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2000 | 6297 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 174 | 0.020 |
Why?
|
Critical Care | 1 | 2022 | 2697 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 851 | 0.020 |
Why?
|
Milk | 1 | 2012 | 443 | 0.020 |
Why?
|
Reference Standards | 1 | 1993 | 1004 | 0.020 |
Why?
|
Middle Aged | 3 | 2020 | 220382 | 0.020 |
Why?
|
Disease Progression | 2 | 2016 | 13484 | 0.020 |
Why?
|
Arginine | 1 | 2012 | 933 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 1997 | 1087 | 0.020 |
Why?
|
Probiotics | 1 | 2012 | 378 | 0.020 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2008 | 64 | 0.020 |
Why?
|
Data Collection | 1 | 1997 | 3321 | 0.020 |
Why?
|
Lipogenesis | 1 | 2010 | 210 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8479 | 0.020 |
Why?
|
Milk, Human | 1 | 2012 | 484 | 0.020 |
Why?
|
Siblings | 1 | 2012 | 825 | 0.020 |
Why?
|
Cognition | 2 | 2017 | 6973 | 0.020 |
Why?
|
Germany | 1 | 2009 | 873 | 0.020 |
Why?
|
Caloric Restriction | 1 | 2010 | 299 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5865 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2073 | 0.020 |
Why?
|
Escherichia coli | 1 | 2019 | 4234 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13616 | 0.020 |
Why?
|
Odds Ratio | 2 | 2013 | 9639 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9598 | 0.020 |
Why?
|
Mental Disorders | 1 | 2006 | 6831 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2014 | 936 | 0.020 |
Why?
|
Trace Elements | 1 | 2007 | 195 | 0.020 |
Why?
|
Medical Errors | 1 | 2014 | 1260 | 0.020 |
Why?
|
Quality of Life | 1 | 2007 | 13338 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2493 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2011 | 1736 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2017 | 2622 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3571 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 4010 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 26063 | 0.020 |
Why?
|
Gestational Age | 1 | 2014 | 3574 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3419 | 0.020 |
Why?
|
Antioxidants | 1 | 2013 | 1670 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3092 | 0.020 |
Why?
|
Transcription Factors | 1 | 2004 | 12121 | 0.010 |
Why?
|
Treatment Failure | 1 | 2010 | 2642 | 0.010 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2006 | 232 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2010 | 1814 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8522 | 0.010 |
Why?
|
Patient Readmission | 1 | 2018 | 3249 | 0.010 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2004 | 135 | 0.010 |
Why?
|
Premature Birth | 1 | 2016 | 1780 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14397 | 0.010 |
Why?
|
Breast Feeding | 1 | 2011 | 1357 | 0.010 |
Why?
|
Aged | 3 | 2023 | 168840 | 0.010 |
Why?
|
Mice, Obese | 1 | 2004 | 420 | 0.010 |
Why?
|
Signal Transduction | 2 | 2019 | 23397 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12054 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4316 | 0.010 |
Why?
|
Pediatrics | 1 | 2018 | 3593 | 0.010 |
Why?
|
Gastrointestinal Agents | 1 | 2007 | 510 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3798 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2462 | 0.010 |
Why?
|
Neutrophils | 1 | 2015 | 3764 | 0.010 |
Why?
|
Prognosis | 2 | 2016 | 29551 | 0.010 |
Why?
|
Retina | 1 | 2012 | 2652 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10494 | 0.010 |
Why?
|
Necrosis | 1 | 2006 | 1604 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 1993 | 2224 | 0.010 |
Why?
|
Biopsy | 1 | 2013 | 6765 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4780 | 0.010 |
Why?
|
Cholesterol | 1 | 2010 | 2902 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29831 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 2379 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9309 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10538 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1301 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2012 | 1890 | 0.010 |
Why?
|
Hospitalization | 2 | 2016 | 10698 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12918 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15698 | 0.010 |
Why?
|
Postoperative Period | 1 | 2004 | 1807 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 8163 | 0.010 |
Why?
|
Protoplasts | 1 | 1997 | 45 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7996 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8826 | 0.010 |
Why?
|
Mycoses | 1 | 2000 | 386 | 0.010 |
Why?
|
Sepsis | 1 | 2010 | 2583 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20078 | 0.010 |
Why?
|
Medical Records | 1 | 2000 | 1407 | 0.010 |
Why?
|
Cell Wall | 1 | 1997 | 425 | 0.010 |
Why?
|
Research Design | 1 | 2010 | 6168 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2000 | 1952 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 1997 | 2189 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2000 | 5491 | 0.000 |
Why?
|
Brain | 1 | 2012 | 27060 | 0.000 |
Why?
|
Algorithms | 1 | 2002 | 14002 | 0.000 |
Why?
|
Neoplasms | 1 | 2010 | 22083 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 36362 | 0.000 |
Why?
|